{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:35:07Z","timestamp":1791128107442,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T00:00:00Z","timestamp":1351468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/onc.2012.493","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T11:14:07Z","timestamp":1351509247000},"page":"4825-4835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":303,"title":["Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity"],"prefix":"10.1038","volume":"32","author":[{"given":"A","family":"Arlt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Geismann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-L","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"BFonc2012493_CR1","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1038\/onc.2009.264","volume":"28","author":"A Arlt","year":"2009","unstructured":"Arlt A, Bauer I, Schafmayer C, Tepel J, Muerkoster SS, Brosch M et al. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2). Oncogene 2009; 28: 3983\u20133996.","journal-title":"Oncogene"},{"key":"BFonc2012493_CR2","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.ejca.2009.05.017","volume":"45","author":"H Akhdar","year":"2009","unstructured":"Akhdar H, Loyer P, Rauch C, Corlu A, Guillouzo A, Morel F . Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur J Cancer 2009; 45: 2219\u20132227.","journal-title":"Eur J Cancer"},{"key":"BFonc2012493_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM DeNicola","year":"2011","unstructured":"DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011; 475: 106\u2013109.","journal-title":"Nature"},{"key":"BFonc2012493_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MPA.0b013e3181c31314","volume":"39","author":"YB Hong","year":"2010","unstructured":"Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH et al. Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas 2010; 39: 463\u2013472.","journal-title":"Pancreas"},{"key":"BFonc2012493_CR5","doi-asserted-by":"publisher","first-page":"5486","DOI":"10.1158\/0008-5472.CAN-10-0713","volume":"70","author":"T Jiang","year":"2010","unstructured":"Jiang T, Chen N, Zhao F, Wang XJ, Kong B, Zheng W et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res 2010; 70: 5486\u20135496.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR6","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-10-3007","volume":"71","author":"TH Kim","year":"2011","unstructured":"Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1alpha. Cancer Res 2011; 71: 2260\u20132275.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.freeradbiomed.2008.05.011","volume":"45","author":"SK Kim","year":"2008","unstructured":"Kim SK, Yang JW, Kim MR, Roh SH, Kim HG, Lee KY et al. Increased expression of Nrf2\/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells. Free Radic Biol Med 2008; 45: 537\u2013546.","journal-title":"Free Radic Biol Med"},{"key":"BFonc2012493_CR8","doi-asserted-by":"publisher","first-page":"5081","DOI":"10.1158\/0008-5472.CAN-10-4668","volume":"71","author":"PA Konstantinopoulos","year":"2011","unstructured":"Konstantinopoulos PA, Spentzos D, Fountzilas E, Francoeur N, Sanisetty S, Grammatikos AP et al. Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer. Cancer Res 2011; 71: 5081\u20135089.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-4598-10-37","volume":"10","author":"A Lister","year":"2011","unstructured":"Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, Lloyd B et al. Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer 2011; 10: 37.","journal-title":"Mol Cancer"},{"key":"BFonc2012493_CR10","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1371\/journal.pmed.0030420","volume":"3","author":"A Singh","year":"2006","unstructured":"Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO et al. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006; 3: e420.","journal-title":"PLoS Med"},{"key":"BFonc2012493_CR11","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-09-3352","volume":"16","author":"LM Solis","year":"2010","unstructured":"Solis LM, Behrens C, Dong W, Suraokar M, Ozburn NC, Moran CA et al. Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features. Clin Cancer Res 2010; 16: 3743\u20133753.","journal-title":"Clin Cancer Res"},{"key":"BFonc2012493_CR12","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1007\/s11033-011-1266-4","volume":"39","author":"Y Hu","year":"2012","unstructured":"Hu Y, Ju Y, Lin D, Wang Z, Huang Y, Zhang S et al. Mutation of the Nrf2 gene in non-small cell lung cancer. Mol Biol Rep 2012; 39: 4743\u20134747.","journal-title":"Mol Biol Rep"},{"key":"BFonc2012493_CR13","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.2653","volume":"220","author":"YR Kim","year":"2010","unstructured":"Kim YR, Oh JE, Kim MS, Kang MR, Park SW, Han JY et al. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin. J Pathol 2010; 220: 446\u2013451.","journal-title":"J Pathol"},{"key":"BFonc2012493_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bbrc.2008.06.004","volume":"373","author":"R Wang","year":"2008","unstructured":"Wang R, An J, Ji F, Jiao H, Sun H, Zhou D . Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem Biophys Res Commun 2008; 373: 151\u2013154.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012493_CR15","doi-asserted-by":"publisher","first-page":"40725","DOI":"10.1074\/jbc.M111.275495","volume":"286","author":"G Eades","year":"2011","unstructured":"Eades G, Yang M, Yao Y, Zhang Y, Zhou Q . miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011; 286: 40725\u201340733.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.bbrc.2007.08.051","volume":"362","author":"P Nioi","year":"2007","unstructured":"Nioi P, Nguyen T . A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun 2007; 362: 816\u2013821.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012493_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2011.10.005","volume":"20","author":"L Kinch","year":"2011","unstructured":"Kinch L, Grishin NV, Brugarolas J . Succination of Keap1 and activation of Nrf2-dependent antioxidant pathways in FH-deficient papillary renal cell carcinoma type 2. Cancer Cell 2011; 20: 418\u2013420.","journal-title":"Cancer Cell"},{"key":"BFonc2012493_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.ccr.2011.09.006","volume":"20","author":"J Adam","year":"2011","unstructured":"Adam J, Hatipoglu E, O'Flaherty L, Ternette N, Sahgal N, Lockstone H et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif\/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 2011; 20: 524\u2013537.","journal-title":"Cancer Cell"},{"key":"BFonc2012493_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mrfmmm.2009.09.007","volume":"690","author":"J Kim","year":"2010","unstructured":"Kim J, Cha YN, Surh YJ . A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Mutat Res 2010; 690: 12\u201323.","journal-title":"Mutat Res"},{"key":"BFonc2012493_CR20","doi-asserted-by":"publisher","first-page":"40911","DOI":"10.1074\/jbc.M111.274902","volume":"286","author":"S Sebens","year":"2011","unstructured":"Sebens S, Bauer I, Geismann C, Grage-Griebenow E, Ehlers S, Kruse ML et al. Inflammatory macrophages induce NRF2 dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection. J Biol Chem 2011; 286: 40911\u201340921.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR21","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3109\/10715762.2010.507670","volume":"44","author":"S Singh","year":"2010","unstructured":"Singh S, Vrishni S, Singh BK, Rahman I, Kakkar P . Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radic Res 2010; 44: 1267\u20131288.","journal-title":"Free Radic Res"},{"key":"BFonc2012493_CR22","doi-asserted-by":"publisher","first-page":"E763","DOI":"10.1210\/jc.2010-2642","volume":"96","author":"ZX Du","year":"2011","unstructured":"Du ZX, Yan Y, Zhang HY, Liu BQ, Gao YY, Niu XF et al. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells. J Clin Endocrinol Metab 2011; 96: E763\u2013E771.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFonc2012493_CR23","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1089\/ars.2010.3219","volume":"13","author":"A Singh","year":"2010","unstructured":"Singh A, Bodas M, Wakabayashi N, Bunz F, Biswal S . Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal 2010; 13: 1627\u20131637.","journal-title":"Antioxid Redox Signal"},{"key":"BFonc2012493_CR24","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.freeradbiomed.2009.09.006","volume":"47","author":"GS Shim","year":"2009","unstructured":"Shim GS, Manandhar S, Shin DH, Kim TH, Kwak MK . Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway. Free Radic Biol Med 2009; 47: 1619\u20131631.","journal-title":"Free Radic Biol Med"},{"key":"BFonc2012493_CR25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1089\/ars.2010.3301","volume":"13","author":"DD Zhang","year":"2010","unstructured":"Zhang DD . The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer. Antioxid Redox Signal 2010; 13: 1623\u20131626.","journal-title":"Antioxid Redox Signal"},{"key":"BFonc2012493_CR26","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1158\/0008-5472.CAN-10-3007","volume":"71","author":"TH Kim","year":"2011","unstructured":"Kim TH, Hur EG, Kang SJ, Kim JA, Thapa D, Lee YM et al. NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1\u03b1. Cancer Res 2011; 71: 2260\u20132275.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR27","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.1158\/0008-5472.CAN-05-0201","volume":"65","author":"L Chen","year":"2005","unstructured":"Chen L, Madura K . Increased proteasome activity, ubiquitin-conjugating enzymes, and eEF1A translation factor detected in breast cancer tissue. Cancer Res 2005; 65: 5599\u20135606.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR28","first-page":"1247","volume":"22","author":"XT Hu","year":"2009","unstructured":"Hu XT, Chen W, Zhang FB, Shi QL, Hu JB, Geng SM et al. Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration. Oncol Rep 2009; 22: 1247\u20131252.","journal-title":"Oncol Rep"},{"key":"BFonc2012493_CR29","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/sj.onc.1203462","volume":"19","author":"S Ren","year":"2000","unstructured":"Ren S, Smith MJ, Louro ID, McKie-Bell P, Bani MR, Wagner M et al. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma. Oncogene 2000; 19: 1419\u20131427.","journal-title":"Oncogene"},{"key":"BFonc2012493_CR30","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1021\/pr8000892","volume":"7","author":"JH Rho","year":"2008","unstructured":"Rho JH, Qin S, Wang JY, Roehrl MH . Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. J Proteome Res 2008; 7: 2959\u20132972.","journal-title":"J Proteome Res"},{"key":"BFonc2012493_CR31","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1074\/jbc.M211898200","volume":"278","author":"MK Kwak","year":"2003","unstructured":"Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW . Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 2003; 278: 8135\u20138145.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR32","doi-asserted-by":"publisher","first-page":"8786","DOI":"10.1128\/MCB.23.23.8786-8794.2003","volume":"23","author":"MK Kwak","year":"2003","unstructured":"Kwak MK, Wakabayashi N, Greenlaw JL, Yamamoto M, Kensler TW . Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway. Mol Cell Biol 2003; 23: 8786\u20138794.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012493_CR33","doi-asserted-by":"publisher","first-page":"8171","DOI":"10.1074\/jbc.M109.031575","volume":"285","author":"S Kapeta","year":"2010","unstructured":"Kapeta S, Chondrogianni N, Gonos ES . Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 2010; 285: 8171\u20138184.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR34","doi-asserted-by":"publisher","first-page":"41074","DOI":"10.1074\/jbc.M110.145862","volume":"285","author":"S Schaedler","year":"2010","unstructured":"Schaedler S, Krause J, Himmelsbach K, Carvajal-Yepes M, Lieder F, Klingel K et al. Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem 2010; 285: 41074\u201341086.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.bbrc.2006.05.043","volume":"345","author":"MK Kwak","year":"2006","unstructured":"Kwak MK, Kensler TW . Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR\/Arnt-XRE, pathway. Biochem Biophys Res Commun 2006; 345: 1350\u20131357.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012493_CR36","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1128\/MCB.22.9.2883-2892.2002","volume":"22","author":"MK Kwak","year":"2002","unstructured":"Kwak MK, Itoh K, Yamamoto M, Kensler TW . Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter. Mol Cell Biol 2002; 22: 2883\u20132892.","journal-title":"Mol Cell Biol"},{"key":"BFonc2012493_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.phrs.2008.09.003","volume":"58","author":"A Lau","year":"2008","unstructured":"Lau A, Villeneuve NF, Sun Z, Wong PK, Zhang DD . Dual roles of Nrf2 in cancer. Pharmacol Res 2008; 58: 262\u2013270.","journal-title":"Pharmacol Res"},{"key":"BFonc2012493_CR38","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB . Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603\u20131616.","journal-title":"Free Radic Biol Med"},{"key":"BFonc2012493_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ccr.2011.08.007","volume":"20","author":"A Taguchi","year":"2011","unstructured":"Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faca VM, Kelly-Spratt K et al. Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 2011; 20: 289\u2013299.","journal-title":"Cancer Cell"},{"key":"BFonc2012493_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","volume":"34","author":"JD Hayes","year":"2009","unstructured":"Hayes JD, McMahon M . NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009; 34: 176\u2013188.","journal-title":"Trends Biochem Sci"},{"key":"BFonc2012493_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mrrev.2007.11.006","volume":"659","author":"WO Osburn","year":"2008","unstructured":"Osburn WO, Kensler TW . Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res 2008; 659: 31\u201339.","journal-title":"Mutat Res"},{"key":"BFonc2012493_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","volume":"29","author":"XJ Wang","year":"2008","unstructured":"Wang XJ, Sun Z, Villeneuve NF, Zhang S, Zhao F, Li Y et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008; 29: 1235\u20131243.","journal-title":"Carcinogenesis"},{"key":"BFonc2012493_CR43","doi-asserted-by":"publisher","first-page":"19589","DOI":"10.1073\/pnas.0709483104","volume":"104","author":"XJ Wang","year":"2007","unstructured":"Wang XJ, Hayes JD, Henderson CJ, Wolf CR . Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha. Proc Natl Acad Sci USA 2007; 104: 19589\u201319594.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2012493_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mce.2007.08.011","volume":"278","author":"W Zhou","year":"2007","unstructured":"Zhou W, Lo SC, Liu JH, Hannink M, Lubahn DB . ERRbeta: a potent inhibitor of Nrf2 transcriptional activity. Mol Cell Endocrinol 2007; 278: 52\u201362.","journal-title":"Mol Cell Endocrinol"},{"key":"BFonc2012493_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jnutbio.2010.03.011","volume":"22","author":"U Boettler","year":"2011","unstructured":"Boettler U, Sommerfeld K, Volz N, Pahlke G, Teller N, Somoza V et al. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J Nutr Biochem 2011; 22: 426\u2013440.","journal-title":"J Nutr Biochem"},{"key":"BFonc2012493_CR46","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1158\/0008-5472.CAN-06-1181","volume":"66","author":"S Kannan","year":"2006","unstructured":"Kannan S, Jaiswal AK . Low and high dose UVB regulation of transcription factor NF-E2-related factor 2. Cancer Res 2006; 66: 8421\u20138429.","journal-title":"Cancer Res"},{"key":"BFonc2012493_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molcel.2010.09.012","volume":"40","author":"J Steffen","year":"2010","unstructured":"Steffen J, Seeger M, Koch A, Kruger E . Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell 2010; 40: 147\u2013158.","journal-title":"Mol Cell"},{"key":"BFonc2012493_CR48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.onc.1204168","volume":"20","author":"A Arlt","year":"2001","unstructured":"Arlt A, Vorndamm J, Breitenbroich M, Folsch UR, Kalthoff H, Schmidt WE et al. Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin. Oncogene 2001; 20: 859\u2013868.","journal-title":"Oncogene"},{"key":"BFonc2012493_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1136\/gut.2009.180711","volume":"58","author":"P Fritsche","year":"2009","unstructured":"Fritsche P, Seidler B, Schuler S, Schnieke A, Gottlicher M, Schmid RM et al. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA. Gut 2009; 58: 1399\u20131409.","journal-title":"Gut"},{"key":"BFonc2012493_CR50","first-page":"163","volume":"7","author":"A Stathis","year":"2010","unstructured":"Stathis A, Moore MJ . Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev 2010; 7: 163\u2013172.","journal-title":"Nat Rev"},{"key":"BFonc2012493_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2010.04.108","volume":"396","author":"M Elangovan","year":"2010","unstructured":"Elangovan M, Oh C, Sukumaran L, Wojcik C, Yoo YJ . Functional differences between two major ubiquitin receptors in the proteasome; S5a and hRpn13. Biochem Biophys Res Commun 2010; 396: 425\u2013428.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc2012493_CR52","doi-asserted-by":"publisher","first-page":"32485","DOI":"10.1074\/jbc.M503074200","volume":"280","author":"T Nguyen","year":"2005","unstructured":"Nguyen T, Sherratt PJ, Nioi P, Yang CS, Pickett CB . Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1. J Biol Chem 2005; 280: 32485\u201332492.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR53","doi-asserted-by":"publisher","first-page":"13856","DOI":"10.1074\/jbc.M808084200","volume":"284","author":"SK Niture","year":"2009","unstructured":"Niture SK, Jaiswal AK . Prothymosin-\u03b1 mediates nuclear import of the INrf2\/Cul3_Rbx1 complex to degrade nuclear Nrf2. J Biol Chem 2009; 284: 13856\u201313868.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molcel.2010.02.029","volume":"38","author":"SK Radhakrishnan","year":"2010","unstructured":"Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, Deshaies RJ . Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 2010; 38: 17\u201328.","journal-title":"Mol Cell"},{"key":"BFonc2012493_CR55","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s10555-010-9255-y","volume":"29","author":"Y Xie","year":"2010","unstructured":"Xie Y . Feedback regulation of proteasome gene expression and its implications in cancer therapy. Cancer Metastasis Rev 2010; 29: 687\u2013693.","journal-title":"Cancer Metastasis Rev"},{"key":"BFonc2012493_CR56","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen T, Nioi P, Pickett CB . The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem 2009; 284: 13291\u201313295.","journal-title":"J Biol Chem"},{"key":"BFonc2012493_CR57","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2337\/dc09-0207","volume":"32","author":"AE van Dijk","year":"2009","unstructured":"van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM . Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 2009; 32: 1023\u20131025.","journal-title":"Diabetes Care"},{"key":"BFonc2012493_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1743-7075-8-10","volume":"8","author":"MR Olthof","year":"2011","unstructured":"Olthof MR, van Dijk AE, Deacon CF, Heine RJ, van Dam RM . Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on incretin hormones. Nutr Metab (Lond) 2011; 8: 10.","journal-title":"Nutr Metab (Lond)"},{"key":"BFonc2012493_CR59","first-page":"257","volume":"38","author":"C Geismann","year":"2011","unstructured":"Geismann C, Arlt A, Bauer I, Pfeifer M, Schirmer U, Altevogt P et al. Binding of the transcription factor slug to the L1CAM promoter is essential for transforming growth factor-beta1 (TGF-beta)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells. Int J Oncol 2011; 38: 257\u2013266.","journal-title":"Int J Oncol"},{"key":"BFonc2012493_CR60","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1158\/0008-5472.CAN-04-1626","volume":"65","author":"S M\u00fcerk\u00f6ster","year":"2005","unstructured":"M\u00fcerk\u00f6ster S, Arlt A, Sipos B, Witt M, Gro\u00dfmann M, Kl\u00f6ppel G et al. Increased expression of the E3-ubiquitin ligase receptor subunit \u03b2TRCP1 relates to constitutive NF-\u03baB activation and chemoresistance in pancreatic carcinoma cells. Cancer Res 2005; 65: 1316\u20131324.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2012493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012493","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2012493.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T14:21:24Z","timestamp":1647872484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2012493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":60,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFonc2012493"],"URL":"https:\/\/doi.org\/10.1038\/onc.2012.493","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,29]]},"assertion":[{"value":"13 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}